| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $38K | -98.9% |
| Operating Income | -$38K | +99.6% |
| Pre-tax Income | -$42K | +99.5% |
| Income Tax | $0 | — |
| Net Income | -$42K | +99.5% |
| EPS (Diluted) | $0.00 | +100.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $5K | +212.2% |
| Total Assets | $32K | -45.3% |
| Current Liabilities | $327K | +13.3% |
| Total Liabilities | $327K | +3.6% |
| Stockholders' Equity | -$295K | -14.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37K | -137.6% |
| Financing Cash Flow | $37K | +269.0% |